All PlansCoverageHigh impact
Cardiac Catheter Ablation (CPB 0165, reviewed 2026-08-25)
Aetna·Cardiology, Cardiothoracic Surgery, Critical Care·Surgery
We identified it
Oct 2, 2026
Summary
Aetna's Cardiac Catheter Ablation policy (CPB 0165) was reviewed on August 25, 2026, establishing comprehensive medical necessity criteria for ablation procedures across multiple arrhythmia types including atrial fibrillation, ventricular tachycardia, and accessory pathway disorders. The policy clarifies that pulsed field ablation is an acceptable alternative to radiofrequency ablation, requires electrophysiology studies only if none performed in prior 3 months, and designates specific procedures as experimental/investigational. Billing teams must ensure claims align with the detailed inclusion criteria and avoid billing for non-covered experimental procedures.
Action Required
Immediately: Billing team must review and update authorization/billing guidelines to enforce Aetna's specific medical necessity criteria for each arrhythmia type before submitting claims for CPT codes 33250, 33251, 33254, 33256, 33257, 33259, 33261, 93613, 93650, 93653, and 93654. Providers must document one of the listed qualifying conditions (e.g., symptomatic AF with failed antiarrhythmic therapy, drug-resistant VT, accessory pathway tachycardia) in the medical record. Do NOT bill CPT 93653 or 93654 without an electrophysiology study, except if one was performed within 3 months prior. Reject claims lacking the required qualifying documentation. Ensure billing software flags and denies claims for experimental procedures including alcohol ablation of vein of Marshall (CPT 93650), cardio-neuro-ablation, intra-myocardial infusion-needle catheter ablation, non-invasive radio-ablation, and sinus node-sparing hybrid ablation. Update encounter templates and provider education materials to reflect these requirements. Failure to enforce these criteria will result in claim denials from Aetna.